CAITLIN TILBE: Open Payments
NPI 1871037226 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 42 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $263 |
| Amgen Inc. | 9 | $181 |
| CSL Behring | 6 | $144 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Grifols USA, LLC | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, Andembry, Xembify, Haegarda, VOQUEZNA, DONIDALORSEN.
Industry payments across CT — which companies pay providers there.
